Every time we pass the AI Express, an investor asks a question on the investor interaction platform: Hi Kaipu, the secretary of the board of directors! At present, the task of preventing and controlling the new crown epidemic is arduous. As a new force in the fight against the epidemic, your company is fighting the front line of testing. Thanks for your hard work! Is the 110,000 antigen test kits donated by your company to Hong Kong not long ago under the brand of Hype? Can it be used for home testing? If so, have you obtained a domestic marketing license? Please reply in time to facilitate the public to buy, thank you!
Cap Bio(300639.SZ) stated on the investor interaction platform on March 17 that the new coronavirus 2019-nCoV nucleic acid detection kit (fluorescent PCR method) independently developed by the company is a nucleic acid detection product, not a new crown antigen detection reagent. The novel coronavirus rapid antigen detection kit donated by the company to Hong Kong is not a self-produced product of the company.
(Article source: Daily Economic News)
Article source: Daily Economic News
Responsible editor: 43
Original title: Kaipu Bio: The new coronavirus 2019-nCoV nucleic acid detection kit (fluorescent PCR method) independently developed by the company is a nucleic acid detection product
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
report
Scan the QR code to follow
Oriental Fortune official website WeChat